Exosome Diagnostics Places Its First Early Access Shahky System within a Top 15 Pharmaceutical Laboratory
January 08, 2018 07:56 ET
|
Exosome Diagnostics
Waltham, MA, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics has announced the placement of the world’s first system for exosome specific protein analysis, the Shahky system, within a large...
Top 10 Global Pharmaceutical Manufacturer Sets New Standard for Product Integrity With NanoGuardian
February 13, 2012 09:30 ET
|
NanoGuardian
SKOKIE, IL--(Marketwire - Feb 13, 2012) - NanoGuardian™, a division of NanoInk®, Inc. that delivers on-dose brand protection solutions to fight illegal diversion and counterfeiting,...
Aegerion Pharmaceuticals to Present at the 2011 Canaccord Genuity Growth Conference
August 04, 2011 08:00 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Aug. 4, 2011 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
Preliminary Data From Exploratory Phase II Study Demonstrates Significant Activity of Droxidopa in Adult Attention Deficit Hyperactivity Disorder (ADHD)
July 26, 2011 08:00 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., July 26, 2011 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced positive top-line results of an investigator-led Phase II clinical study of...
Myrexis Announces Executive Management Changes
July 22, 2011 08:30 ET
|
Myrexis, Inc.
SALT LAKE CITY, July 22, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on developing and commercializing novel treatments for cancer, today announced that...
Myrexis to Participate in Stifel Nicolaus 2011 Orphan Drug One-on-One Conference
June 30, 2011 16:00 ET
|
Myrexis, Inc.
SALT LAKE CITY, June 30, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on developing and commercializing novel treatments for cancer, today announced that...
Semafore Pharmaceuticals Reports New Preclinical Data for Multi-Kinase, PI3K/mTOR Inhibitor SF1126 at AACR
April 05, 2011 13:00 ET
|
Semafore Pharmaceuticals
INDIANAPOLIS, April 5, 2011 (GLOBE NEWSWIRE) -- Semafore Pharmaceuticals today announced encouraging preclinical results for its lead product candidate, SF1126, in certain B-cell malignancies. The...
Graymark Healthcare Reports Fiscal 2008 Year End Results
April 01, 2009 08:30 ET
|
Graymark Healthcare, Inc.
OKLAHOMA CITY, April 1, 2009 (GLOBE NEWSWIRE) -- Graymark Healthcare Inc. (Nasdaq:GRMH) today announced results for the year ended December 31, 2008.
During the year ended December 31, 2008, net...
CombiMatrix Announces Positive Preliminary Data on Non-Invasive, Cancer Screening Test
February 26, 2009 06:00 ET
|
CombiMatrix Corporation
MUKILTEO, Wash., Feb. 26, 2009 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) today announced positive preliminary data on its investigational Comprehensive Cancer Array (CCA) test showing...
Tongli Pharmaceuticals Announces Strong Revenue and Net Income Growth in Third Quarter of Fiscal Year 2009
February 17, 2009 09:00 ET
|
Tongli Pharmaceuticals (USA), Inc.
NEW YORK, N.Y., Feb. 17, 2009 (GLOBE NEWSWIRE) -- Tongli Pharmaceuticals (OTCBB:TGLP), a pharmaceutical company specializing in the development, manufacture, and commercialization in the People's...